VEXAS syndrome research reveals overactive bone marrow stem cells may drive inflammation

Researchers at Memorial Sloan Kettering Cancer Center (MSK) have developed some of the first robust laboratory models of a ...

Powerful tool can map gene regulation at single-nucleotide resolution

Understanding how cells turn genes on and off is one of biology's most enduring mysteries. Now, a new technology developed by ...

How a humble weed became a superstar of biology

Arabidopsis thaliana was always an unlikely candidate for the limelight. But 25 years ago, the diminutive thale cress ...
Irish Farmers Journal

Long-standing Suffolk flock to go under the hammer

This week, Nevan McKiernan spoke with Mark Grealy, who is dispersing his highly regarded Oranmore Suffolk flock in Athenry Mart on Friday 7 November.
Le Lézard

Sarepta Therapeutics Announces Third Quarter 2025 Financial Results and Recent Corporate Developments, Including Completion of Its Confirmatory Study, ESSENCE

Sarepta Therapeutics, Inc. , the leader in precision genetic medicine for rare diseases, today reported financial results for the third quarter of 2025 and the completion of ESSENCE, its global, Phase ...